"Hepatitis B virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
| Descriptor ID |
D006515
|
| MeSH Number(s) |
B04.280.375.650.425 B04.450.390.650.425
|
| Concept/Terms |
Hepatitis B virus- Hepatitis B virus
- B virus, Hepatitis
- Hepatitis B viruses
- viruses, Hepatitis B
- Hepatitis Virus, Homologous Serum
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B virus".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B virus".
This graph shows the total number of publications written about "Hepatitis B virus" by people in this website by year, and whether "Hepatitis B virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 2 | 2 |
| 2002 | 1 | 2 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 3 | 6 |
| 2013 | 6 | 0 | 6 |
| 2014 | 0 | 2 | 2 |
| 2015 | 5 | 1 | 6 |
| 2016 | 4 | 2 | 6 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 2 | 3 |
| 2020 | 3 | 0 | 3 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 2 | 4 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B virus" by people in Profiles.
-
Prevalence and factors associated with Hepatitis B infection in the general population: a cross-sectional study in Moshi municipality, North-Eastern Tanzania. Afr Health Sci. 2025 Jun; 25(2):30-37.
-
Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format. J Pediatric Infect Dis Soc. 2024 Nov 21; 13(Supplement_5):S142-S147.
-
IFN-treated macrophage-derived exosomes prevents HBV-HCC migration and invasion via regulating miR-106b-3p/PCGF3/PI3K/AKT signaling axis. Front Cell Infect Microbiol. 2024; 14:1421195.
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
-
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic review. Lancet Infect Dis. 2024 Jun; 24(6):e366-e385.
-
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
-
Feasibility of hepatitis B elimination in high-income countries with ongoing immigration. J Hepatol. 2022 10; 77(4):947-956.
-
Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Rev Med Virol. 2022 11; 32(6):e2353.
-
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus. Clin Gastroenterol Hepatol. 2023 04; 21(4):1111-1113.e3.
-
Hepatitis B and Health Care Workers. Clin Liver Dis. 2021 11; 25(4):859-874.